The program will integrate the Company’s clinically validated NanoVibronix technology to improve comfort associated with indwelling nasogastric tubes…
TYLER, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) — ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing on the advancement of intelligent, non-invasive solutions for ent… [6414 chars]
Source: GlobeNewswire | Published: 2026-01-09T14:01:00Z
Credit: GlobeNewswire
